Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

First Edition: July 11, 2013

Today's early morning highlights from the major news organizations including reports from Capitol Hill about GOP efforts to repeal or delay the health law.

11 Jul 2013

Neuronix to present data on NeuroAD device at Alzheimer's Association International Conference

Neuronix, which has developed an innovative medical device technology for the treatment of Alzheimer's Disease, announces today that it will present at the leading Alzheimer's Association International Conference, in Boston, United States.

11 Jul 2013

Older people with Alzheimer's disease less likely to have cancer and vice versa

Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears in the July 10, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Jul 2013

Study examines whether better sleep lowers risk of heart disease

The University of South Florida College of Nursing is conducting research to improve sleep in those caring for people with dementia and Alzheimer's disease, with the aim of determining if better sleep affects heart health.

10 Jul 2013

Study shows rates of brain loss caused by aging and AD are higher for women

The rates of regional brain loss and cognitive decline caused by aging and the early stages of Alzheimer's disease (AD) are higher for women and for people with a key genetic risk factor for AD, say researchers at the University of California, San Diego School of Medicine in a study published online July 4 in the American Journal of Neuroradiology.

10 Jul 2013

Researchers show cerebrovascular disease affecting blood circulation in brain associated with dementia

Researchers in the Perelman School of Medicine at the University of Pennsylvania found that, across a variety of neurodegenerative diseases, cerebrovascular disease affecting circulation of blood in the brain was significantly associated with dementia.

10 Jul 2013

NeuRA study: Orbitofrontal cortex plays key role in linking emotion, memories in FTD patients

A study by researchers at Neuroscience Research Australia (NeuRA) is the first to demonstrate that patients with frontotemporal dementia (FTD) lose the emotional content/colour of their memories. These findings explain why FTD patients may not vividly remember an emotionally charged event like a wedding or funeral.

9 Jul 2013

Early signs of Alzheimer's disease can be detected years before diagnosis, say researchers

Early signs of Alzheimer's disease can be detected years before diagnosis, according to researchers at Birmingham City University. The study found that sufferers of a specific type of cognitive impairment have an increased loss of cells in certain parts of the brain, which can be vital in detecting which patients will progress to a diagnosis of Alzheimer's.

9 Jul 2013

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Probiodrug AG (Probiodrug) announced that it will be making two poster and two oral presentations at the upcoming Alzheimer's Association International Conference in Boston, MA July 13 - 18, 2013.

8 Jul 2013

Alzheimer's Association upset with CMS draft decision on brain amyloid imaging

The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services draft coverage decision on brain amyloid imaging, particularly given the clear, scientific consensus recommendations provided to CMS by the Association and the Society for Nuclear Medicine and Molecular Imaging regarding appropriate, limited coverage, only in specific populations.

6 Jul 2013

El Lilly calls for Medicare coverage of beta-amyloid imaging agents for Alzheimer's disease

Eli Lilly and Company today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a draft decision proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. Beta-amyloid imaging agents are used to evaluate patients with cognitive impairment for Alzheimer's Disease and other causes of cognitive decline.

5 Jul 2013

Prana gets Austin HREC approval for 12-month open label extension study of PBT2 in Alzheimer’s patients

Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer’s Disease patients participating in Prana’s IMAGINE trial.

4 Jul 2013

Gerovital H3 may be making a comeback, warns BUSM researcher

Despite it being more than 30 years since the "fountain of youth drug" Gerovital H3 was banned in the United States, it may be making a comeback. In an editorial published in this month's Journal of the American Geriatrics Society BUSM researcher Thomas Perls, MD, points out that a few U.S.-based anti-aging and longevity clinics have begun to advertise Gerovital H3 in pill form and as intravenous infusions despite the fact that the U.S. Food and Drug Administration banned it in 1982.

4 Jul 2013

Reading books and participating in brain-stimulating activities may preserve memory

New research suggests that reading books, writing and participating in brain-stimulating activities at any age may preserve memory. The study is published in the July 3, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Jul 2013

Study: Different strains of alpha-synuclein may contribute to different types of brain diseases

It only takes one bad apple to spoil the bunch, and the same may be true of certain proteins in the brain. Studies have suggested that just one rogue protein (in this case, a protein that is misfolded or shaped the wrong way) can act as a seed, leading to the misfolding of nearby proteins.

4 Jul 2013

CRB Bio II, ADE Capital Sodical commit €3M seed investment round in Raman Health Technologies

CRB Bio II, a VC Fund managed by CRB Inverbío, and ADE Capital Sodical, have committed a €3M seed investment round in Raman Health Technologies, a new start up company developing a new non invasive diagnostic technology platform based on Raman laser and Infrarred spectroscopy. Its first indication will be for the early diagnosis of Alzheimer disease in a blood sample.

3 Jul 2013

Patients with high education show less impairment on neuropsychological evaluation

Multiple sclerosis (MS) can lead to severe cognitive impairment as the disease progresses. Researchers in Italy have found that patients with high educational levels show less impairment on a neuropsychological evaluation compared with those with low educational levels. Their results are published in Restorative Neurology and Neuroscience.

3 Jul 2013

Researchers report that aerobic exercise can lessen or worsen ulcerative colitis symptoms

Aerobic exercise can lessen - or worsen - the symptoms of inflammatory bowel diseases such as ulcerative colitis, depending on the circumstances under which the exercise is undertaken, researchers report.

3 Jul 2013

New mechanism triggers chronic inflammation in Alzheimer's, atherosclerosis and type-2 diabetes

Researchers at NYU Langone Medical Center have discovered a mechanism that triggers chronic inflammation in Alzheimer's, atherosclerosis and type-2 diabetes. The results, published today in Nature Immunology, suggest a common biochemical thread to multiple diseases and point the way to a new class of therapies that could treat chronic inflammation in these non-infectious diseases without crippling the immune system.

2 Jul 2013

Increased expression of Scara1 protein might impede progression of Alzheimer's disease: Study

Identification of a protein that appears to play an important role in the immune system's removal of amyloid beta (A-beta) protein from the brain could lead to a new treatment strategy for Alzheimer's disease. The report from researchers at Massachusetts General Hospital (MGH) has been published online in Nature Communications.

2 Jul 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

First Edition: July 11, 2013

Neuronix to present data on NeuroAD device at Alzheimer's Association International Conference

Older people with Alzheimer's disease less likely to have cancer and vice versa

Study examines whether better sleep lowers risk of heart disease

Study shows rates of brain loss caused by aging and AD are higher for women

Researchers show cerebrovascular disease affecting blood circulation in brain associated with dementia

NeuRA study: Orbitofrontal cortex plays key role in linking emotion, memories in FTD patients

Early signs of Alzheimer's disease can be detected years before diagnosis, say researchers

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Alzheimer's Association upset with CMS draft decision on brain amyloid imaging

El Lilly calls for Medicare coverage of beta-amyloid imaging agents for Alzheimer's disease

Prana gets Austin HREC approval for 12-month open label extension study of PBT2 in Alzheimer’s patients

Gerovital H3 may be making a comeback, warns BUSM researcher

Reading books and participating in brain-stimulating activities may preserve memory

Study: Different strains of alpha-synuclein may contribute to different types of brain diseases

CRB Bio II, ADE Capital Sodical commit €3M seed investment round in Raman Health Technologies

Patients with high education show less impairment on neuropsychological evaluation

Researchers report that aerobic exercise can lessen or worsen ulcerative colitis symptoms

New mechanism triggers chronic inflammation in Alzheimer's, atherosclerosis and type-2 diabetes

Increased expression of Scara1 protein might impede progression of Alzheimer's disease: Study

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in